Specify a stock or a cryptocurrency in the search bar to get a summary
PolTREG S.A.
PTGPoltreg S.A., a biotechnology company, develops therapies for autoimmune diseases. It engages in the research and development of therapies for the treatment of type 1 diabetes in children, and multiple sclerosis. The company was incorporated in 2016 and is based in Gdansk, Poland. Address: Waly Piastowskie 1 lok. 1508, Gdansk, Poland, 80-855
Analytics
WallStreet Target Price
214.2 PLNP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures PTG
Dividend Analytics PTG
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History PTG
Stock Valuation PTG
Financials PTG
Results | 2019 | Dynamics |